| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.32 | 0.08 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.096 | 0.08 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |